Skip to main content

Hautuki Patch Demonstrates Growth Potential and Safety in Clinical Study

Hautuki Clinically Proven to Support Height Growth and Ensure Safety

Custics announced that its height-supporting nutrient patch, Hautuki, has been proven effective and safe through a clinical study conducted at Bestian Hospital over the course of approximately one year.

The study was conducted over 11 months, from January to November 2024, and involved 40 children between the ages of 5 and 12.

After eight weeks, the group that used the Hautuki patch showed an average height increase of 0.4 cm more than the control group—representing a growth difference of approximately 30%. These results scientifically support Hautuki’s effectiveness in promoting height growth.

The study also confirmed the product’s safety. No side effects were reported throughout the study period, even with long-term use, confirming Hautuki’s favorable safety profile.

Kangil Lee, CEO of Custics Inc., stated, “Through this clinical study, we were able to confirm that Hautuki is a safe and effective product for children and adolescents during their growth periods. We will continue our efforts to deliver trustworthy products to our customers.”

With these results, Hautuki is gaining increased consumer trust as a growth support solution and plans to further strengthen its market presence through continued research and product refinement.

For more information, please visit - https://www.hautuki.sg/products/hautuki-growth-acceleration-patch

Media Contact
Company Name: Grow With Amit
Contact Person: Amit Biswas
Email: Send Email
Country: India
Website: https://www.fiverr.com/grow_withamit

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.